Key result
S-ICD and epicardial ablation prevent recurrent VT for 4 months in a single myocarditis patient.
Case Report (n=1)
Epicardial ablation targeting late potentials can successfully treat myocarditis-related VT in patients with a subcutaneous ICD.
May prompt CMR in unexplained VT with normal LV function; leaves open its effect on management and outcomes.
A 56-year-old patient who experienced a first-time syncope and a sustained monomorphic ventricular tachycardia (VT), treated with DC-shock, was documented (Panel A). Echocardiography and cardiac catheterization were unremarkable. Cardiac magnetic resonance imaging (CMR) revealed the presence of a delayed focal enhancement of gadolinium in the epicardial layer of the lateral wall and a normal left ventricular systolic function (Panels B and C). The diagnosis of chronic myocarditis was indicated. The patient refused implantation of a transvenous implantable cardioverter-defibrillator (ICD). On the basis of the presence of fast VT and the absence of a bradycardic pacing indication, an entirely subcutaneous ICD (Cameron Health, San Clemente, CA, USA) was implanted. After a 2-month period, the patient had two appropriate shocks for VT despite treatment with sotalol and was referred for VT ablation (Panel D). The patient underwent bipolar and unipolar endocardial electroanatomical mapping with the CARTO-3 System (Biosense-Webster, Diamond Bar, CA, USA) and a 3.5-mm distal-tip irrigated ablation catheter (Navistar Thermocool, Biosense-Webster, Inc.), which demonstrated the absence of the scar tissue area (Panel E). Epicardial mapping, obtained via a subxyphoid approach, did not also exhibit the scar area (voltage cut-off <1.0 mV), although a late potentials area was detected in the basal-medium segment of the lateral wall in the colour-coded map of the activation delay (Panel F). The ablation catheter was placed on a late potentials area, taking into consideration the course of coronary vessels, and complete abolition was achieved on the basis of a subsequent remap (Panels G–H). The patient, first to be treated consecutively with S-ICD and epicardial ablation, is free of recurrent VT or ventricular ectopic activity after a 4-month period. Cardiac magnetic resonance appears to be more sensitive for fibrosis detection compared with electroanatomical mapping, taking into consideration the thresholds applied.
No takes yet. Share an insight, caveat, or question.
Mazzone et al. (2012) conducted a case report in Myocarditis-related ventricular tachycardia (n=1). Subcutaneous ICD and epicardial ablation was evaluated on Recurrent VT or ventricular ectopic activity. A 56-year-old patient treated with a subcutaneous ICD and epicardial ablation for myocarditis-related ventricular tachycardia remained free of recurrent VT or ventricular ectopic activity at 4 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: